| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/10/1997 | WO1997024373A1 Monoclonal antibody antagonists to haemopoietic growth factors |
| 07/10/1997 | WO1997024371A1 Product derived from milk substantially free of beta casein from non-human mammals and relative use |
| 07/10/1997 | WO1997024370A1 Novel antigenic proteins of mycoplasmata, genes thereof, and recombinant vector and use of the same |
| 07/10/1997 | WO1997024140A1 Interaction of hla proteins with members of the hsp70 family of proteins |
| 07/10/1997 | WO1997024139A1 Peanut allergens and methods |
| 07/10/1997 | WO1997024137A1 HYBRID WITH INTERFERON-α AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 07/10/1997 | WO1997024133A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 07/10/1997 | WO1997024111A2 Novel hyaluronic acid receptors binding agents and the use thereof |
| 07/10/1997 | WO1997024057A2 Screening tests for lytic cycle antigens and antibodies to kaposi's sarcoma-associated herpesvirus |
| 07/10/1997 | WO1997018305A3 Method to prepare drug-resistant, non-malignant hematopoietic cells |
| 07/10/1997 | WO1997012974A3 Kidney atp-dependent potassium channels |
| 07/10/1997 | WO1997012850A3 Bifunctional, sulphide-containing sulphonamide-chelating agents of xsny type for radioactive isotopes |
| 07/10/1997 | CA2254791A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 07/10/1997 | CA2241373A1 Compositions and methods for t-cell activation comprising gm-csf and tumor antigen fusion proteins |
| 07/10/1997 | CA2241317A1 Novel polynucleotides panc1a and panc1b associated with pancreatic cancer |
| 07/10/1997 | CA2241280A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 07/10/1997 | CA2240578A1 Receptor specific chimeric viral surface polypeptides for viral and particle incorporation and internalization in target cells |
| 07/10/1997 | CA2240292A1 Recombinant fusion proteins to growth hormone and serum albumin |
| 07/10/1997 | CA2239522A1 Hybrid with interferon-.alpha. and an immunoglobulin fc linked through a non-immunogenic peptide |
| 07/10/1997 | CA2239299A1 Ligand polypeptides for the g-protein-coupled receptor protein, their production and use |
| 07/10/1997 | CA2238885A1 Nucleic acids encoding interferon gamma inducing factor-2 |
| 07/10/1997 | CA2238307A1 Ob protein derivatives having prolonged half-life |
| 07/10/1997 | CA2211685A1 Novel yeast gene |
| 07/09/1997 | EP0783104A1 Method for assaying soluble amyloid precursor protein |
| 07/09/1997 | EP0783038A1 Recombinant viral pseudoparticles and their applications as vaccines or as antitumour agents |
| 07/09/1997 | EP0783037A1 Polypeptides with a dopaminergic receptor (D2-R and D3-R) activity and use of these polypeptides to screen substances having a selective activity on these polypeptides |
| 07/09/1997 | EP0783003A1 Novel polypeptides |
| 07/09/1997 | EP0783002A2 Dual action inhibitors |
| 07/09/1997 | EP0782630A1 Polycystic kidney disease gene |
| 07/09/1997 | EP0782625A1 Expression and export technology of proteins as immunofusins |
| 07/09/1997 | EP0782624A1 Picornavirus l proteinase and methods of making and using thereof |
| 07/09/1997 | EP0782620A1 A novel fungal multisubunit protein complex critical for expression of fungal proteins |
| 07/09/1997 | EP0782619A1 Novel pka-binding proteins and uses thereof |
| 07/09/1997 | EP0782618A2 Allelic variation of the serotonin 5ht 2c? receptor |
| 07/09/1997 | EP0782617A1 gp130 LACKING THE TRANSMEMBRANE DOMAIN |
| 07/09/1997 | EP0782615A1 Dna encoding human papillomavirus type 6a |
| 07/09/1997 | EP0782614A1 Direct introduction of foreign materials into cells |
| 07/09/1997 | EP0782584A1 Il-1 receptor antagonists with enhanced inhibitory activity |
| 07/09/1997 | EP0782583A1 Method of measuring thymopoietin proteins in plasma and serum |
| 07/09/1997 | EP0782580A1 Parallel selex |
| 07/09/1997 | EP0782454A1 Use of muramyl peptide compounds |
| 07/09/1997 | EP0782453A1 Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 07/09/1997 | EP0584232B1 Novel bacillus thuringiensis isolates for controlling acarides |
| 07/09/1997 | EP0551324B1 Salmonella polynucleotide sequence |
| 07/09/1997 | EP0478775B1 Peptide derivatives |
| 07/09/1997 | CN1154144A Isolated, tyrosinase derived peptides and uses thereof |
| 07/09/1997 | CN1154143A Synthetic leader peptide sequences |
| 07/09/1997 | CN1154142A Transgenic fish in the treatment of diabetes |
| 07/09/1997 | CN1154117A Synthetic peptide analogs of lung surfactant protein SP-C |
| 07/09/1997 | CN1154116A Peptide |
| 07/09/1997 | CN1154072A Technetium-99m labeled peptides for imaging |
| 07/09/1997 | CN1154071A Radiolabeled compounds for thrombus imaging |
| 07/09/1997 | CN1153785A Cyclic vasoactive peptide analogs |
| 07/09/1997 | CN1153784A Biotin derivatives |
| 07/08/1997 | US5646333 Plant promoter useful for directing the expression of foreign proteins to the plant epidermis |
| 07/08/1997 | US5646302 Heterotrifunctional compounds for photoaffinity labelling |
| 07/08/1997 | US5646301 Incorporation into peptides |
| 07/08/1997 | US5646259 DNA encoding haemophilus adhesion proteins |
| 07/08/1997 | US5646255 Reaction product of protein, succinimide derivative and tetrapeptide sequence of valine-histidine-leucine-threonine |
| 07/08/1997 | US5646254 Treating inflammation in humans and animals |
| 07/08/1997 | US5646252 Hemoglobin composition and preparation thereof |
| 07/08/1997 | US5646251 Alloreaction-associated antigen (ARAG): a novel member of the immunoglobulin gene superfamily |
| 07/08/1997 | US5646250 Cadherin polypeptides |
| 07/08/1997 | US5646249 Genetic engineering |
| 07/08/1997 | US5646248 E-selection binding soluble lamp-1 polypeptide |
| 07/08/1997 | US5646247 Merozoite antigens localized at the apical end of the parasite |
| 07/08/1997 | US5646242 Amidation of insulin or derivative with soluble, activated fatty acid ester; one step |
| 07/08/1997 | US5646185 Administering protein kinase c activator consisting of phorbol ester, diacylglycerol, or thapsigargin to hypoxic cells |
| 07/08/1997 | US5646156 Administering xanthine derivative as antiinflammatory agent or antiallergen |
| 07/08/1997 | US5646119 D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents |
| 07/08/1997 | US5646117 Therapeutic agent for treating wounds using monocyte chemotactic and activating factor |
| 07/08/1997 | US5646115 Diagnosing allergic dermatitis; desensitizing animals to flea bites |
| 07/08/1997 | US5646113 Treatment of partial growth hormone insensitivity syndrome |
| 07/08/1997 | US5646110 Cyclic peptides |
| 07/08/1997 | US5646043 Culturing a hematopoeitic stem cell composition |
| 07/08/1997 | US5646042 C-myb targeted ribozymes |
| 07/08/1997 | US5646040 Mammalian tub gene |
| 07/08/1997 | US5646037 Novel hybrid vectors based on yeast two micron plasmid;expression of heterologous genes |
| 07/08/1997 | US5646036 Anticarcinogenic agents |
| 07/08/1997 | US5646032 Recombinant foamy virus vectors for medicinal, and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/08/1997 | US5646030 Method for isolating mutant cells |
| 07/08/1997 | US5646029 Genetically engineered replacement for products derived from plant gums such as guar and gum arabic |
| 07/08/1997 | US5646026 Ribosome-inactivating proteins, inactive precursor forms thereof, a process for making and a method of using |
| 07/08/1997 | US5646024 Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants |
| 07/08/1997 | US5646020 Hammerhead ribozymes for preferred targets |
| 07/08/1997 | US5646017 Methods of generating desired amino-terminal residues in proteins |
| 07/08/1997 | US5646016 Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules |
| 07/08/1997 | US5646014 Peptide, antibacterial agent, peptide gene, recombinant DNA and method for preparing the peptide |
| 07/08/1997 | US5646013 Method of producing foreign gene products |
| 07/08/1997 | US5646011 Overcoming resistance of tumor cells to chemotheraputic agents, gene expression |
| 07/08/1997 | US5646010 Methods and compositions for expression of competent eukaryotic gene products |
| 07/08/1997 | US5646008 Vertebrate apoptosis gene: compositions and methods |
| 07/08/1997 | US5645999 Assays for compounds that modulate or alter cyclin E activity |
| 07/08/1997 | US5645998 Detection of immunocomplex formed by glutamic acid decarboxylase protein with autoantibodies |
| 07/08/1997 | US5645997 Assay and treatment for demyelinating diseases such as multiple sclerosis, related hybridomas and monoclonal antibodies |
| 07/08/1997 | US5645996 Melittin-related polypeptides, mixture sets and libraries thereof |
| 07/08/1997 | US5645983 Elisa, antibody-antigen complex |
| 07/08/1997 | US5645838 Antigen |
| 07/08/1997 | US5645837 Drugs to inhibit rejection of organ rejection after grafting; bone marrow grafting |
| 07/08/1997 | US5645835 Therapeutic antibody based fusion proteins |